A Phase 2, 28-Day, Multicenter, Double-Blind,Randomized, Placebo-Controlled Study to Assess the Safety, Tolerability and Efficacy of MB07803 in Patients With Type 2 Diabetes Mellitus.

Trial Profile

A Phase 2, 28-Day, Multicenter, Double-Blind,Randomized, Placebo-Controlled Study to Assess the Safety, Tolerability and Efficacy of MB07803 in Patients With Type 2 Diabetes Mellitus.

Completed
Phase of Trial: Phase II

Latest Information Update: 29 Sep 2011

At a glance

  • Drugs VK 0612 (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions; Proof of concept; Therapeutic Use
  • Most Recent Events

    • 11 Aug 2011 Company added as reported by ClinicalTrials.gov.
    • 08 Aug 2008 Results to be presented at The World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension, Barcelona, Spain, October 2008.
    • 29 Apr 2008 Status changed from in progress to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top